+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts in vitro studies in rat hepatocytes and human erythrocytes

Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts in vitro studies in rat hepatocytes and human erythrocytes

Hepatology 14(5): 920-926

Intraduodenal infusion of hydrophobic bile salts to bile-fistula rats leads within hours to severe hepatocellular necrosis and cholestasis; simultaneous administration of conjugates of ursodeoxycholate, either intraduodenally or intravenously, reduces or prevents liver injury. To evaluate the short-term protective effects of ursodeoxycholate at the cellular level, we incubated primary monolayer cultures of adult rat hepatocytes or freshly isolated washed human erythrocytes for 1 to 240 min with varying defined concentrations of different bile salts in the presence or absence of ursodeoxycholate. Cytolysis was quantified by measuring the release into the medium of cytosolic lactate dehydrogenase (hepatocytes) or hemoglobin (erythrocytes). In both systems, cytolysis increases sigmoidally with increasing bile salt concentration, and the relative toxicity of different bile salts proceeded in the following order: tauroursodeoxycholate was less toxic than taurocholate, which was less toxic than taurodeoxycholate. Taurochenodeoxycholate was more toxic to erythrocytes than taurodeoxycholate; the two were equally toxic to rat hepatocytes. Unconjugated bile salts were more toxic than their conjugates. The addition of tauroursodeoxycholate to taurochendoeoxycholate or taurodeoxycholate led to time-dependent and concentration-dependent reduction or elimination of the toxicity of the more hydrophobic component. Protection was evident within minutes. With respect to hemolysis, at pH 8.5 glyco was less protective than taurousodeoxycholate, and free ursodeoxychlate was only minimally protective. We conclude conclude that the hepatocytotoxicity of hydrophobic bile salts at millimolar concentrations is markedly reduced in the presence of tauroursodeoxycholate. Conjugates of ursodeoxycholate also prevented disruption of erythrocytes by bile salts, suggesting that protection does not depend on liver-specific pathways of bile salt uptake, compartmentation, transport or metabolism. We hypothesize that ursodeoxycholate interferes with solubilization of membranes by bile salts; in vivo, ursodeoxycholate may improve cholestatic liver disease by reducing the toxicity of endogenous bile salts at the luminal surface of the canalicular plasma membrane.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 007152916

Download citation: RISBibTeXText

PMID: 1937396

DOI: 10.1002/hep.1840140527

Related references

Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat. Gastroenterology 100(1): 203-211, 1991

Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. Gastroenterology 100(1): 203-211, 1991

Conjugates of ursodeoxycholic acid udc protect human red blood cells rbc in vitro against membrane disrupting effects of more hydrophobic bile salts bs. Hepatology 10(4): 728, 1989

Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts. Gastroenterology 106(5): 1333-1341, 1994

Bile salt-induced cytotoxicity and ursodeoxycholate cytoprotection: in-vitro study in perifused rat hepatocytes. European Journal of Gastroenterology and Hepatology 9(7): 703-709, 1997

Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology 12(3 PART 1): 486-491, 1990

Ursodeoxycholate cytoprotection against hepatocyte killing by hydrophobic bile salts cannot be explained solely by changes in the hydrophobicity index. Hepatology 16(4 PART 2): 134A, 1992

Comparison study on cytotoxicity of sodium tauroursodeoxycholate and other human 11 bile salts in rat hepatocytes. Japanese Journal of Pharmacology 67(SUPPL 1): 200P, 1995

Substitution of ursodeoxycholate for toxic bile salts ameliorates mitochondrial damage caused by bile salts and calcium. Gastroenterology 108(4 SUPPL ): A1035, 1995

Protective actions of tauro-ursodeoxycholate and tauro-beta-muricholate against gastric mucosal injury induced by more hydrophobic bile salts. Gastroenterology 104(4 SUPPL ): A115, 1993

Thermodynamic and molecular basis for dissimilar cholesterol-solubilizing capacities by micellar solutions of bile salts: cases of sodium chenodeoxycholate and sodium ursodeoxycholate and their glycine and taurine conjugates. Biochemistry 20(12): 3637-3648, 1981

Bile salts induce calcium uptake in vitro by human erythrocytes. Hepatology 7(2): 245-252, 1987

Ursodeoxycholate reduces toxicity of different bile acids in human primary hepatocytes cultures. Gastroenterology 96(5 PART 2): A599, 1989

Tauroursodeoxycholate does not protect freshly isolated rat liver cells against toxic effects of more hydrophobic bile salts. Gastroenterology 102(4 PART 2): A881, 1992

Cholesterol crystals enhance and phospholipids protect against pancreatitis induced by hydrophobic bile salts: a rat model study. Pancreas 32(4): 369-375, 2006